MIR4802

Across TCGA pan-cancer cohorts, MIR4802 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR4802 data layer.

The strongest signal is observed in thymoma (THYM), where higher MIR4802 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4802 expression acts as an unfavorable survival marker, although some lineages such as LUAD and STAD show a favorable association.

THYM, MESO, and CESC are the cancer types where MIR4802 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	III,IV	0.103	0.944	<.001	78	view →
MESO	OS	Tertile	III,IV	0.036	0.563	<.001	54	view →
CESC	DFS	Tertile	IV	0.053	0.529	<.001	54	view →
ACC	DFS	Tertile	All	0.117	0.656	<.001	42	view →
THCA	DFS	Tertile	II,III,IV	0.307	0.732	.001	36	view →
LIHC	DFS	Tertile	II,III,IV	0.100	0.429	<.001	27	view →
DLBC	DFS	Tertile	III,IV	0.137	0.790	<.001	18	view →
UCS	OS	Tertile	II,III,IV	0.247	0.621	.046	18	view →
PCPG	DFS	Tertile	All	0.562	0.911	.003	18	view →
LUAD	DFS	Tertile	IV	1.000	0.279	.029	12	view →
ESCA	OS	Median	All	0.440	1.000	.008	7	view →
OV	OS	Median	III,IV	0.265	0.356	.027	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR4802–THYM (OS)

Open the THYM breakdown →